By ROBERT CYRAN
The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.
Published: February 2, 2016 at 12:00AM
from NYT Business Day http://ift.tt/23En9bW
from WordPress http://ift.tt/23EpGmE
via Hadi Aboukhater
No comments:
Post a Comment